Cleared Traditional

K072374 - COMPASS

K072374 is an FDA 510(k) clearance for COMPASS, manufactured by Scanditronix Wellhofer GmbH. The device is a Class 2 Radiology device with product code IYE cleared through the Traditional 510(k) pathway after a 106-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2007
Decision
106d
Days
Class 2
Risk

K072374 is an FDA 510(k) clearance for the COMPASS. Classified as Accelerator, Linear, Medical (product code IYE), Class II - Special Controls.

Submitted by Scanditronix Wellhofer GmbH (Schwarzenbruck, DE). The FDA issued a Cleared decision on December 7, 2007 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Scanditronix Wellhofer GmbH devices

FDA 510(k) Submission Details - K072374

510(k) Number K072374 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 23, 2007
Decision Date December 07, 2007
Days to Decision 106 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
1d faster than avg
Panel avg: 107d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IYE Device Classification - Class 2, Special Controls

Product Code IYE Accelerator, Linear, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYE Accelerator, Linear, Medical

All 410
Devices cleared under the same product code (IYE) and FDA review panel - the closest regulatory comparables to K072374.
STEREOTACTIC TARGET POSITIONER, TARGET POSITIONER FOR LEKSELL HEADRING, STEREOTACTIC COUNTERWEIGHT
K073018 · Brainlab AG · Jan 2008
ARTISTE MV SA
K072485 · Siemens Medical Solutions USA, Inc. · Dec 2007
EQUAL DOSE 1.0
K073273 · Nucletron Corporation · Dec 2007
TRILOGY SYSTEM WITH RAPIDARC
K072916 · Varian Medical Systems, Inc. · Nov 2007
EXACTRAC 5.5
K072506 · Brainlab AG · Oct 2007
TRACKPORT
K072529 · Direx Systems Corp. · Oct 2007